SCHEMBL528887

SCHEMBL528887

CNN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15388363 1.00
SCHEMBL6670546 0.96 CARM1 (0.33)
Hydrochloric Acid SCHEMBL1026800 0.96
SCHEMBL1092361 0.96
Bromide SCHEMBL4361146 0.96
SCHEMBL528404 0.96
SCHEMBL25769149 0.96 CARM1 (0.33)
Hydrochloric Acid SCHEMBL1027109 0.93 CARM1 (0.32)
Hydrochloric Acid SCHEMBL28745686 0.93 CARM1 (0.32)
Bromide SCHEMBL7065182 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210399111-A1 TITANIUM ALUMINUM AND TANTALUM ALUMINUM THIN FILMS ASM IP HOLDING B.V. (NL) 2021-12-23 US claimed
US-11139383-B2 Titanium aluminum and tantalum aluminum thin films ASM IP HOLDING B.V. (NL) 2021-10-05 US claimed
US-20200328285-A1 TITANIUM ALUMINUM AND TANTALUM ALUMINUM THIN FILMS ASM IP HOLDING B.V. (NL) 2020-10-15 US claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-9255324-B2 Aluminum precursor composition UP CHEMICAL CO., LTD. (KR) 2016-02-09 US claimed
WO-2014027861-A1 ALUMINUM PRECURSOR COMPOSITION UP CHEMICAL CO., LTD. (KR) 2014-02-20 WO claimed
US-20140050848-A1 ALUMINUM PRECURSOR COMPOSITION UP CHEMICAL CO., LTD. (KR) 2014-02-20 US claimed
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
US-20250320213-A1 Nitrogen-Containing Heterocyclic Compounds PFIZER INC. (US) 2025-10-16 US disclosed
US-20250213555-A1 SUBSTITUTED TETRAHYDROFURAN ANALOGS AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-07-03 US disclosed
EP-4441042-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-10-09 EP disclosed
US-20240317775-A1 H4 Antagonist Compounds NXERA PHARMA UK LIMITED (GB) 2024-09-26 US disclosed
EP-4400504-A1 THIOPHENE RING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences (CN) 2024-07-17 EP disclosed
WO-2024138206-A1 FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF FRONTIER MEDICINES CORPORATION (US) 2024-06-27 WO disclosed
CN-1036958-A The preparation method of acyl derivative HOFFMANN LA ROCHE (CH) 1989-11-08 CN disclosed
CN-1030237-A BENZOHETEROCYCLIC COMPOUNDS OTSUKA PHARMA CO LTD (JP) 1989-01-11 CN disclosed
EP-0287951-A2 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-10-26 EP disclosed
US-4767769-A HISTAMINE-H2 ANTAGONISTS THE BOOTS COMPANY PLC (GB) 1988-08-30 US disclosed
EP-0228061-A2 Cephem compounds Takeda Chemical Industries, Ltd. (JP) 1987-07-08 EP disclosed
EP-0160969-A2 Cephem compounds Takeda Chemical Industries, Ltd. (JP) 1985-11-13 EP disclosed